FDA Investigator Barbara M Frazier

Barbara M Frazier has inspections in 19 countries as of 22 Sep 2023. Barbara M Frazier has collaborated with a combinined 6524 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
204
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, India, United States of America, Canada, France, Germany, Estonia, Sweden, Chile, Ireland, Netherlands, Russian Federation, Poland, Belgium, Costa Rica, Spain, Switzerland, South Africa
Co-Investigator(s):
Adam R Cooke, Alberto A Viciedo, Alice S Tsao, Allen F Hall, Amanda E Lewin, PhD, Amy H Ruble, Anastasia M Shields, Andrew Le, Angela E Glenn, Anita R Michael, Ann B Borromeo, Ann L Demarco, Anna Lazar, Anthony J Ladner, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Ashar P Parikh, Babatunde D Babalola, Barbara A Rusin, Barbara Frazier, Barbara J Rincon, Barbara Janine Breithaupt, Barbara M Frazir, Barbara M Frezior, Barbara M Frizior, Betsy C Galliher, Billy M Battles, Bonita S Chester, Bradley Dworak, PhD, Brandy D Brown, Brian D Nicholson, Brian J Ryan, Bridegan, Brown, Bruce H Mccullough, Brunilda Torres, Buford, Burnell M Henry, Carl A Huffman, III, Carl J Montgomery, Carla J Lundi, Carlos M Gonzalez, Carol L Rehkopf, Caryn M Mcnab, CDR Donald Ertel, CDR Jeremy L Wally, PhD, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charles I Ann, Charles L Larson, Charles R Cote, RIC, Cherrie A Zachary, Cheryl A Clausen, Chestnut, Chris A Sack, Christian D Lynch (CDL), Christina V Santos, Christine H Kujawski, Christine M Smith, Christopher R Czajka, Claire M Minden, Claudette D Brooks, Concepcion Cruz, Jr, Contractor Bridgers, Courtney N Long, Craig A Garmendia, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Cynthia L Rakestraw, Damon C Green, MD,MS, Daniel C Kearns, Daniel L Aisen, Daphne Santiago, PhD, Darla J Christopher, David J Gomes, David Perkins, David R Heiar, Debra I Love, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Derek C Price, Devaugh Edwards, Devaughn Edwards, Diane L Raccasi, Donald C Obenhuber, PhD, Donald L Lech, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edecia A Richards, Edwin Melendez, Eileen J Bannerman, Eric L Dong, BS, Eric M Mueller, PharmD, Erin C Hill, Felix Maldonado, Frederick Razzaghi, Gabriel Davila, Gabriel R Mclemore, Gale E Ryan, Gamal A Norton, Gene D Arcy, Geoffrey K Kilili, George C Amedro, Gerald B Seaborn, Jr, Gerald Mierle, Gideon N Esuzor, Gloria E Parra, Gulshan R Anand, Gwyn G Dickinson, Hai Lien T Phung, Heather M Wheeler, Hector A Carrero, Hector J Colon Torres, Heika R Tait, Helen B Ricalde, Helen Verdel, Hyojong Kwon, PhD, Inga M Warr, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, James A Lane, James C Maclaughlin, James L Dunnie, Jr, James M Kewley, James R Evans, James R Fleckenstein, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jason K Morgan, Javier O Vega, Jawaid Hamid, Jeanne D Shaffer, Jennifer Alongie Vollom, Jennifer C Adams, Jennifer D Hollstrom, Jennifer L Sheehan, Joan A Loreng, Joanne E King, Joe A Odom, Joel D Martinez, Joey V Quitania, John A Gonzalez, John A Kadavil, PhD, Jonah S Ufferfilge, Jonathan G Matrisciano, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose R Hernandez, Joseph F Owens, Julie D Bringger, Kara D Dobbin, Karen M Cooper, Karen M Kondas, Karen Takahashi, Kassa Ayalew, MD, Kathleen D Culver, Katie L Penno, Katrina B Mosley Sloan, Kellia N Hicks, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kip J Hanks, Kirtida Patel, Kristen D Evans, Kula N Jha, Kumar G Janoria, Lance M De Souza, MBA, Larry K Austin, Larry K Hampton, Laura E Garcia, Laurel A Beer, Lauryl A Smith, Lawrence Carter, III, Lawrence Y Lee, PhD, LCDR Debra Emerson, Lesley K Satterwhite, Li Hongpaul Yeh, PhD, Libia M Lugo, Lillie D Witcher, Linda R Kuchenthal, Lisa P Oakes, Lori A Gioia, LT Tamara J Henderson, Luis A Dasta, Luis M Burgos Medero, Lynda L Lanning, Marcia A Worley, Marcus F Yambot, Margaret M Annes, Maria A Ruttell, Marianela Aponte Cruz, Marie F Morin, Marisa E Stock, Mariza M Jafary, Marshalette O Edwards, Martin K Yau, PhD, Mathew T Thomas, MD, Matthew A Spataro, Matthew B Casale, Matthew C Watson, Matthew J Gretkierewicz, Melanie M Walker, Melanie W Pishnery, Melkamu Getie Kebtie, PhD, Metitia G Sanders, Metitia M Gramby, Michael F Skelly, PhD, Michael J Nerz, Michael J Verdi, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle D Haamid, Michelle Haamid, Michelle Y Clark Stuart, Mihaly S Ligmond, Monica Cburgos Garcia, Morrell, Mra Mcculloughj, Nancy A Bellamy, Ni A Khin, MD, Nicholas L Paulin, Nicola M Fenty Stewart, Nicole A Lloyd, Nicole E Knowlton, Nicole M Bell, Nigel L Hirth, Niketa Patel, Nilufer M Tampal, PhD, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Patricia F Hudson, Patty P Kaewussdangkul, Paul A Bonneau, Paul M Kawamoto, Paula A Trost, Paula M Laplant, Peggy M Speight, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qiao Y Bobo, Ralph A Erickson, Randy L Clarida, Raymond T Oji, Reba A Gates, Rebecca Parrilla, Rebecca T Davis, Regina T Brown, Rhonda Alexander, Richard E Needham, Richard H Penta, Richard Heath Coats, Richard J Friedman, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Doyle, Robert J Ham, Robert W Jennings, Rodney T Allnutt, Rose M Ashley, Rose Xu, Roy R Rinc, Ruben C Ayala, PharmD, Russell J Glapion, S Lori Brown, PhD MPH, Saied A Asbagh, Samantha J Pinizzotto, D V M, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Sayeeda Hdabe, Scott B Laufenberg, Scott T Ballard, Sean R Bryd, Sean R Marcsisin, Seneca D Toms, Seongeun Cho (Julia), PhD, Sereen Gmorgan Murray, Sharon K Thoma, PharmD, Shawn E Larson, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sirram Subramaniam, Sixto M Mercado Rios, Sneha S Patel, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Srira Subramaniam, PhD, Sriram Subramanham, Srlram Subramaniam, PhD, Stacey S Degarmo, Stacie A Woods, Stephanie E Hubbard, Stephanie L Shapley, Steven C Madzo, Steven D Kehoe, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan O Oladeji, Susant Hadman, Suzanne N Vallez, Tajah L Blackburn, Tamara M Felton, Tamika D Cathey, Tamil Arasu, PhD, Tammara A Stephens, Ted L Anderson, Theressa B Smith, Thomas J Arista, Thomas R Withers, Thomas W Nojek, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tina M Pawlowski, Tomika L Bivens, Tonshina R Hall, Tracy R Ball, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vanessa E Coulter, Vicky C Stoakes, Viviana Matta, Wei Wang, PhD, Wendy G Tan, PhD, William P Tonkins, Williams, Wr Bowman, Xiaokuang Lai, PhD, Xiomara Copeland, Yiyue Zhang (nmi), PhD, Yong Hu, Yonggang Wang, PhD, Yun Wu, PhD, Yvins Dezan, Yvonne E Lozano, Zachary A Bogorad, Zhong Li, PhD

Barbara M Frazier's Documents

Publish Date Document Type Title
August, 2007 EIR AM2 PAT INC - EIR, 2007-08-02
May, 2006 FDA 483 Response Patheon Softgels Inc. - Form 483R, 2006-06-14
June, 2002 FDA 483 Response Prof. Stephen Martin, M.D. - Form 483R, 2002-06-21
December, 2002 EIR Richard H. Weisler - EIR, 2002-12-30
June, 2002 EIR Dr. Veronica Larach, M.D. - EIR, 2002-06-14
October, 2003 EIR Dr. Andres Sild - EIR, 2003-11-12
May, 2003 FDA 483 Response American Cardiovascular Res Ins - Form 483R, 2003-06-06
April, 2000 EIR Kopp, Elliot MD - EIR, 2000-04-07
December, 2010 FDA 483 Moehs Cantabra SL - Form 483, 2010-12-17
December, 2000 EIR Becton Dickinson Corporate Preclinical Development and Toxicology - EIR, 2000-12-07
November, 2001 FDA 483 Response Adriano Arguedas Mohs, M.D. - Form 483R, 2001-12-21
May, 2006 EIR Patheon Softgels Inc. - EIR, 2006-05-17
September, 2007 EIR Experimental Pathology Labs - EIR, 2007-09-20
August, 2002 FDA 483 GlaxoSmithKline - Form 483, 2002-08-02
November, 2000 EIR Experimental Pathology Labs - EIR, 2000-11-21
September, 2000 EIR Siegfried Hameln GmbH - EIR, 2001-01-04
May, 2003 FDA 483 American Cardiovascular Res Ins - Form 483, 2003-05-09
May, 2005 FDA 483 Synchrony Labs, LLC - Form 483, 2005-05-12
September, 2003 FDA 483 PPD Development LP - Form 483, 2003-09-25
August, 2000 FDA 483 Blue Ridge Pharmaceuticals, Inc - Form 483, 2000-08-28
December, 2002 FDA 483 Richard H. Weisler - Form 483, 2002-12-30
April, 2007 EIR Patheon Softgels Inc. - EIR, 2007-04-12
April, 2002 FDA 483 Duke University Medical Center - Dept. of Psych and Beh Sci - Form 483, 2002-04-09
May, 2004 FDA 483 Charles Sheaffer MD - Form 483, 2004-05-20
November, 2002 EIR IQVIA - EIR, 2002-11-20
August, 2001 FDA 483 Patheon Manufacturing Services LLC - Form 483, 2001-08-30
September, 2008 EIR CMP Pharma, Inc. - EIR, 2008-09-11
March, 2002 EIR Laboratory Corporation of America - EIR, 2002-03-14
August, 2001 EIR Patheon Manufacturing Services LLC - EIR, 2001-08-30
December, 2010 EIR ZACH SYSTEM S.A. - EIR, 2010-12-02
April, 2001 FDA 483 Mark Chandler MD - Form 483, 2001-04-09
May, 2003 EIR American Cardiovascular Res Ins - EIR, 2003-05-09
September, 2010 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2010-09-10
July, 2002 EIR Stephen Bernard, M.D. - EIR, 2002-07-24
December, 2002 EIR Hospira, Inc. - EIR, 2002-12-10
January, 2002 FDA 483 Biovail Contract Research - Form 483, 2002-01-31
February, 2001 EIR GTF Gesellschaft für Therapeutische Forschung - EIR, 2001-02-01
September, 2000 FDA 483 Response Siegfried Hameln GmbH - Form 483R, 2000-09-27
June, 2002 FDA 483 Response Dr. Veronica Larach, M.D. - Form 483R, 2002-06-14
March, 2000 FDA 483 AAI Pharma - Form 483, 2000-03-10
July, 2002 EIR Integrated Laboratory Systems LLC, An Inotiv Company - EIR, 2002-07-15
June, 2000 FDA 483 Research Triangle Institute - Form 483, 2000-06-09
May, 2006 FDA 483 Patheon Softgels Inc. - Form 483, 2006-05-17
July, 2000 FDA 483 Wayne Lee Harper, MD - Form 483, 2000-07-27
December, 2010 EIR Moehs Cantabra SL - EIR, 2010-12-17
May, 2002 EIR Donohue, James F - MD - EIR, 2002-05-31
July, 2006 EIR Charles River Laboratories Clinical Services - EIR, 2006-07-21
January, 2002 FDA 483 Response MDS Pharma (Dr. Wence Tong) - Form 483R, 2002-02-01
November, 2007 FDA 483 GlaxoSmithKline - Form 483, 2007-11-13
July, 2000 EIR CATO Research - EIR, 2000-07-05
October, 2001 EIR Dr. Marc Robert - EIR, 2001-10-24
November, 2000 FDA 483 Experimental Pathology Labs - Form 483, 2000-11-21
March, 2005 FDA 483 ACCUTEST RESEARCH LABORATORIES ( I ) - Form 483, 2005-03-17
June, 2000 EIR Research Triangle Institute - EIR, 2000-06-09
April, 2007 FDA 483 Response Patheon Softgels Inc. - Form 483R, 2007-05-01
October, 2003 EIR Dr. Alan Wade - EIR, 2003-10-23
March, 2005 EIR ACCUTEST RESEARCH LABORATORIES ( I ) - EIR, 2005-03-17
September, 2000 FDA 483 Pharma Hameln GmbH - Form 483, 2000-09-15
April, 2002 EIR DORAISWAMY P MURALI MD - EIR, 2002-04-09
July, 2002 FDA 483 Integrated Laboratory Systems LLC, An Inotiv Company - Form 483, 2002-07-15
January, 2002 FDA 483 MDS Pharma (Dr. Wence Tong) - Form 483, 2002-01-25
January, 2002 EIR Catalent Pharma Solutions, LLC - EIR, 2002-01-07
March, 2001 FDA 483 Grifols Therapeutics LLC - Form 483, 2001-03-21
January, 2002 EIR MDS Pharma (Dr. Wence Tong) - EIR, 2002-01-25
October, 2003 FDA 483 Response Dr. Andres Sild - Form 483R, 2003-12-08
August, 2001 FDA 483 Response Patheon Manufacturing Services LLC - Form 483R, 2001-09-28
March, 2001 EIR Grifols Therapeutics LLC - EIR, 2001-03-21
December, 2006 FDA 483 Leiner Health Products, Llc - Form 483, 2006-12-19
March, 2002 FDA 483 Laboratory Corporation of America - Form 483, 2002-03-14
October, 2003 FDA 483 Response Dr. Alan Wade - Form 483R, 2003-10-23
August, 2002 EIR GlaxoSmithKline - EIR, 2002-08-02
May, 2002 FDA 483 UNC - Pulmonary Division - Form 483, 2002-05-31
April, 2001 EIR Mark Chandler MD - EIR, 2001-04-09
September, 2001 EIR Laurel Stadtmauer MD - EIR, 2001-09-05
March, 2001 FDA 483 Response Grifols Therapeutics LLC - Form 483R, 2001-06-08
January, 2000 EIR Bioanalytika Laboratories Inc - EIR, 2000-01-12
August, 2001 EIR Med-El Corporation - EIR, 2001-08-20
June, 2004 FDA 483 Response Johan Maertens, M.D. - Form 483R, 2004-06-25
March, 2000 EIR AAI Pharma - EIR, 2000-03-10
July, 2002 FDA 483 aaiPharma - Form 483, 2002-07-30
July, 2000 EIR Wayne Lee Harper, MD - EIR, 2000-07-27
April, 2007 FDA 483 Patheon Softgels Inc. - Form 483, 2007-04-12
August, 2000 EIR Idexx Pharmaceuticals Inc - EIR, 2000-08-28
May, 2004 EIR Charles Sheaffer MD - EIR, 2004-05-20
August, 2003 EIR GlaxoSmithKline - EIR, 2003-08-07
June, 2002 EIR Prof. Stephen Martin, M.D. - EIR, 2002-06-21
January, 2003 EIR Krishnan, K. Ranga MD - EIR, 2003-01-27
November, 2001 EIR Adriano Arguedas Mohs, M.D. - EIR, 2001-11-19
May, 2010 FDA 483 Qualiphar Nv - Form 483, 2010-05-07
January, 2002 FDA 483 Syneos Health Clinique Inc - Form 483, 2002-01-21
April, 2000 FDA 483 Kopp, Elliot MD - Form 483, 2000-04-07
November, 2001 FDA 483 C/O ICIC LATIN AMERICA - Form 483, 2001-11-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more